Antivirals Discovery and Development Platform
The antivirals discovery and development platform offers high throughput analysis of antiviral candidate compounds free of charge to Welsh researchers. Analyses include:
- virus infected cell viability/ cell toxicity (selective index);
- replicon assays to assess prodrug nucleo-sidic compounds, and
- RNA polymerase assays.
Platform data will be fed into dedicated research projects to develop leads and establish MoA. Construction of new replicon tools will be a sideline of the screening effort. The platform promotes collaboration between chemists and life science researchers in Wales and will have a capacity of up to 600 compounds per month.
For further information please contact:
Dr. Andrea Brancale